Results 201 to 210 of about 129,145 (314)
Phytochemical Investigation of an Ostrya carpinifolia L. Extract: An Effective Anti-Pollution Cosmetic Active Ingredient. [PDF]
Trinel M +6 more
europepmc +1 more source
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
Camellia Sinensis Extracts Embedded in Semipermeable Nanocapsules as Active Ingredient for Dental Adhesives: Biomaterial Synthesis and Effect on the Bond to Human Dentin. [PDF]
Richter-Mendau P +4 more
europepmc +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Analysis of the Aerial Parts of <i>Millettia speciosa</i> Champ. and Mechanistic Study of Its Active Ingredient Formononetin in Improving Metabolic Syndrome. [PDF]
Niu W, Jian R, Zeng L, Huang Z, Cai J.
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence. [PDF]
Szendzielorz E, Spiewak R.
europepmc +1 more source

